Biologics

Aziyo Biologics names Dr. Randal Mills interim president and CEO

Aziyo Biologics co-founder Randal Mills, PhD, was named interim president and CEO.

By: Carly Behm

Wednesday, June 22nd, 2022

Dr. Mills replaces Ronald Lloyd, who is stepping down later in 2022, according to a Jun 21 news release. Aziyo co-founder Kevin Rakin will also assume the role of executive chair.

Dr. Mills and Mr. Rakin founded Aziyo Biologics in 2015.

Next Up in Biologics

World Economic Forum Awards Xenco Medical with Prestigious 2025 Award for Excellence in Governance and Leadership for Global Challenges

For its groundbreaking work in sustaining global health systems in a year of geopolitical turbulence, Xenco Medical has been awarded…

By: Staff
Tuesday, December 2nd, 2025
3 key spine biologics partnerships shaping 2025

Spine biologics companies are navigating unprecedented commercial pressure and accelerating technological change. As demand for regenerative solutions grows and competition…

By: Sophie Eydis
Tuesday, November 25th, 2025
BioRestorative secures key FDA meeting for spine therapy approval

Melville, N.Y.-based BioRestorative Therapies has secured a Type B meeting with the FDA to discuss an accelerated approval path for…

By: Sophie Eydis
Tuesday, November 25th, 2025

Comments are closed.

How AdventHealth unlocked $24M in 4 months

Next Up in Biologics

World Economic Forum Awards Xenco Medical with Prestigious 2025 Award for Excellence in Governance and Leadership for Global Challenges

3 key spine biologics partnerships shaping 2025

BioRestorative secures key FDA meeting for spine therapy approval

Join the spine leaders & surgeons who start their day with Becker's